NM_004260.4:c.2545G>A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004260.4(RECQL4):c.2545G>A(p.Val849Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000494 in 1,578,360 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RECQL4 | ENST00000617875.6 | c.2545G>A | p.Val849Met | missense_variant | Exon 15 of 21 | 1 | NM_004260.4 | ENSP00000482313.2 | ||
RECQL4 | ENST00000621189.4 | c.1474G>A | p.Val492Met | missense_variant | Exon 14 of 20 | 1 | ENSP00000483145.1 | |||
RECQL4 | ENST00000534626.6 | c.715G>A | p.Val239Met | missense_variant | Exon 6 of 8 | 5 | ENSP00000477457.1 | |||
ENSG00000265393 | ENST00000580385.1 | n.271+220C>T | intron_variant | Intron 1 of 1 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152250Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000767 AC: 15AN: 195490Hom.: 0 AF XY: 0.0000658 AC XY: 7AN XY: 106320
GnomAD4 exome AF: 0.0000365 AC: 52AN: 1426110Hom.: 0 Cov.: 66 AF XY: 0.0000481 AC XY: 34AN XY: 706240
GnomAD4 genome AF: 0.000171 AC: 26AN: 152250Hom.: 0 Cov.: 34 AF XY: 0.000161 AC XY: 12AN XY: 74374
ClinVar
Submissions by phenotype
Ovarian cancer Pathogenic:1
- -
not specified Uncertain:1
DNA sequence analysis of the RECQL4 gene demonstrated a sequence change, c.2545G>A, in exon 15 results in an amino acid change, p.Val849Met. This sequence change does not appear to have been previously described in individuals with RECQL4-related disorders and has been described in the gnomAD database with a low population frequency of 0.071% in the African subpopulation (dbSNP rs201661055). The p.Val849Met change affects a highly conserved amino acid residue located in a domain of the RECQL4 protein that is not known to be functional. The p.Val849Met substitution appears to be deleterious using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD). Due to these contrasting evidences and the lack of functional studies, the clinical significance of the p.Val849Met change remains unknown at this time. -
not provided Uncertain:1
- -
Rothmund-Thomson syndrome type 2 Uncertain:1
The RECQL4 c.2545G>A (p.Val849Met) missense change has a maximum subpopulation frequency of 0.07% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). In silico tools predict a deleterious effect on protein function, but to our knowledge this prediction has not been confirmed by functional studies. To our knowledge, this variant has not been reported in individuals with RECQL4-associated conditions. In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. -
Baller-Gerold syndrome Uncertain:1
This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 849 of the RECQL4 protein (p.Val849Met). This variant is present in population databases (rs201661055, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with RECQL4-related conditions. ClinVar contains an entry for this variant (Variation ID: 239737). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt RECQL4 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at